These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice. Vähätalo LH, Ruohonen ST, Mäkelä S, Kovalainen M, Huotari A, Mäkelä KA, Määttä JA, Miinalainen I, Gilsbach R, Hein L, Ailanen L, Mattila M, Eerola K, Röyttä M, Ruohonen S, Herzig KH, Savontaus E. Acta Physiol (Oxf); 2015 Apr; 213(4):902-19. PubMed ID: 25482272 [Abstract] [Full Text] [Related]
3. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons. Ailanen L, Ruohonen ST, Vähätalo LH, Tuomainen K, Eerola K, Salomäki-Myftari H, Röyttä M, Laiho A, Ahotupa M, Gylling H, Savontaus E. J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933 [Abstract] [Full Text] [Related]
4. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance. Ruohonen ST, Pesonen U, Moritz N, Kaipio K, Röyttä M, Koulu M, Savontaus E. Diabetes; 2008 Jun; 57(6):1517-25. PubMed ID: 18276767 [Abstract] [Full Text] [Related]
5. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnanský R, Zukowska Z. Ann N Y Acad Sci; 2008 Dec; 1148():232-7. PubMed ID: 19120115 [Abstract] [Full Text] [Related]
7. The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity. Mattila M, Söderström M, Ailanen L, Savontaus E, Savontaus M. Cardiovasc Toxicol; 2020 Jun; 20(3):328-338. PubMed ID: 31811615 [Abstract] [Full Text] [Related]
8. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons. Ruohonen ST, Savontaus E, Rinne P, Rosmaninho-Salgado J, Cavadas C, Ruskoaho H, Koulu M, Pesonen U. Neuroendocrinology; 2009 Jun; 89(3):351-60. PubMed ID: 19122447 [Abstract] [Full Text] [Related]
10. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation. Zhang L, Lee NJ, Nguyen AD, Enriquez RF, Riepler SJ, Stehrer B, Yulyaningsih E, Lin S, Shi YC, Baldock PA, Herzog H, Sainsbury A. Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734 [Abstract] [Full Text] [Related]
19. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY. Mashiko S, Ishihara A, Iwaasa H, Sano H, Oda Z, Ito J, Yumoto M, Okawa M, Suzuki J, Fukuroda T, Jitsuoka M, Morin NR, MacNeil DJ, Van der Ploeg LH, Ihara M, Fukami T, Kanatani A. Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685 [Abstract] [Full Text] [Related]
20. Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y. Corder KM, Li Q, Cortes MA, Bartley AF, Davis TR, Dobrunz LE. Neuropeptides; 2020 Feb; 79():101979. PubMed ID: 31708112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]